quest pharm limited
quest pharm limited Company Information
Company Number
11267746
Next Accounts
Jan 2025
Industry
Manufacture of pharmaceutical preparations
Shareholders
majad hussain
yasar hussain
Group Structure
View All
Contact
Registered Address
alexander house, 60-61 tenby street north, birmingham, B1 3EG
Website
-quest pharm limited Estimated Valuation
Pomanda estimates the enterprise value of QUEST PHARM LIMITED at £2.3m based on a Turnover of £2.4m and 0.96x industry multiple (adjusted for size and gross margin).
quest pharm limited Estimated Valuation
Pomanda estimates the enterprise value of QUEST PHARM LIMITED at £5.6m based on an EBITDA of £1.3m and a 4.32x industry multiple (adjusted for size and gross margin).
quest pharm limited Estimated Valuation
Pomanda estimates the enterprise value of QUEST PHARM LIMITED at £11m based on Net Assets of £4.5m and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Quest Pharm Limited Overview
Quest Pharm Limited is a live company located in birmingham, B1 3EG with a Companies House number of 11267746. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in March 2018, it's largest shareholder is majad hussain with a 50% stake. Quest Pharm Limited is a young, small sized company, Pomanda has estimated its turnover at £2.4m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Quest Pharm Limited Health Check
Pomanda's financial health check has awarded Quest Pharm Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 4 areas for improvement. Company Health Check FAQs
7 Strong
1 Regular
4 Weak
Size
annual sales of £2.4m, make it smaller than the average company (£25.5m)
- Quest Pharm Limited
£25.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 24%, show it is growing at a faster rate (0.4%)
- Quest Pharm Limited
0.4% - Industry AVG
Production
with a gross margin of 14.7%, this company has a higher cost of product (33.4%)
- Quest Pharm Limited
33.4% - Industry AVG
Profitability
an operating margin of 54.2% make it more profitable than the average company (6%)
- Quest Pharm Limited
6% - Industry AVG
Employees
with 5 employees, this is below the industry average (99)
5 - Quest Pharm Limited
99 - Industry AVG
Pay Structure
on an average salary of £54.7k, the company has an equivalent pay structure (£54.7k)
- Quest Pharm Limited
£54.7k - Industry AVG
Efficiency
resulting in sales per employee of £478.6k, this is more efficient (£253.7k)
- Quest Pharm Limited
£253.7k - Industry AVG
Debtor Days
it gets paid by customers after 146 days, this is later than average (57 days)
- Quest Pharm Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 161 days, this is slower than average (36 days)
- Quest Pharm Limited
36 days - Industry AVG
Stock Days
it holds stock equivalent to 12 days, this is less than average (115 days)
- Quest Pharm Limited
115 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 249 weeks, this is more cash available to meet short term requirements (10 weeks)
249 weeks - Quest Pharm Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 16.7%, this is a lower level of debt than the average (44.9%)
16.7% - Quest Pharm Limited
44.9% - Industry AVG
QUEST PHARM LIMITED financials
Quest Pharm Limited's latest turnover from April 2023 is estimated at £2.4 million and the company has net assets of £4.5 million. According to their latest financial statements, Quest Pharm Limited has 5 employees and maintains cash reserves of £4.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Turnover | |||||
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | |||||
| Tax | |||||
| Profit After Tax | |||||
| Dividends Paid | |||||
| Retained Profit | |||||
| Employee Costs | |||||
| Number Of Employees | 5 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Tangible Assets | 27,961 | 16,991 | 6,204 | 4,455 | 2,124 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 27,961 | 16,991 | 6,204 | 4,455 | 2,124 |
| Stock & work in progress | 69,556 | 71,513 | 67,314 | 68,071 | 0 |
| Trade Debtors | 958,978 | 749,707 | 156,635 | 448,210 | 920,912 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 |
| Cash | 4,326,698 | 3,441,566 | 2,504,009 | 1,273,822 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 |
| total current assets | 5,355,232 | 4,262,786 | 2,727,958 | 1,790,103 | 920,912 |
| total assets | 5,383,193 | 4,279,777 | 2,734,162 | 1,794,558 | 923,036 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 900,823 | 893,749 | 806,285 | 189,796 | 630,878 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 461,162 | 0 |
| total current liabilities | 900,823 | 893,749 | 806,285 | 650,958 | 630,878 |
| loans | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 900,823 | 893,749 | 806,285 | 650,958 | 630,878 |
| net assets | 4,482,370 | 3,386,028 | 1,927,877 | 1,143,600 | 292,158 |
| total shareholders funds | 4,482,370 | 3,386,028 | 1,927,877 | 1,143,600 | 292,158 |
| Apr 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 8,469 | 4,247 | 1,612 | 1,160 | |
| Amortisation | 0 | 0 | 0 | 0 | |
| Tax | |||||
| Stock | -1,957 | 4,199 | -757 | 68,071 | 0 |
| Debtors | 209,271 | 593,072 | -291,575 | -472,702 | 920,912 |
| Creditors | 7,074 | 87,464 | 616,489 | -441,082 | 630,878 |
| Accruals and Deferred Income | 0 | 0 | -461,162 | 461,162 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||
| interest | |||||
| cash flow from financing | |||||
| cash and cash equivalents | |||||
| cash | 885,132 | 937,557 | 1,230,187 | 1,273,822 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 |
| change in cash | 885,132 | 937,557 | 1,230,187 | 1,273,822 | 0 |
quest pharm limited Credit Report and Business Information
Quest Pharm Limited Competitor Analysis
Perform a competitor analysis for quest pharm limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in B 1 area or any other competitors across 12 key performance metrics.
quest pharm limited Ownership
QUEST PHARM LIMITED group structure
Quest Pharm Limited has no subsidiary companies.
Ultimate parent company
QUEST PHARM LIMITED
11267746
quest pharm limited directors
Quest Pharm Limited currently has 2 directors. The longest serving directors include Dr Majad Hussain (Aug 2019) and Mr Yasar Hussain (Aug 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Majad Hussain | United Kingdom | 49 years | Aug 2019 | - | Director |
| Mr Yasar Hussain | United Kingdom | 48 years | Aug 2024 | - | Director |
P&L
April 2023turnover
2.4m
-3%
operating profit
1.3m
0%
gross margin
14.7%
-29.03%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2023net assets
4.5m
+0.32%
total assets
5.4m
+0.26%
cash
4.3m
+0.26%
net assets
Total assets minus all liabilities
Similar Companies
quest pharm limited company details
company number
11267746
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
March 2018
age
6
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
April 2023
previous names
N/A
accountant
-
auditor
-
address
alexander house, 60-61 tenby street north, birmingham, B1 3EG
Bank
-
Legal Advisor
-
quest pharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to quest pharm limited.
quest pharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
